Status | Study |
Active, not recruiting |
Study Name: Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study Condition: Intermediate Uveitis Posterior Uveitis Date: 2012-10-26 Interventions: Drug: Tocilizumab Tocilizumab (4 mg/kg or 8 mg/kg) O |
Active, not recruiting |
Study Name: Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert Condition: Posterior Uveitis Intermediate Uveitis Date: 2012-09-24 Interventions: Drug: FAI insert Drug: Sham injection |
Recruiting |
Study Name: Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis , Condition: Non-infectious Intermediate Uveitis Non-infectious Posterior Uv Date: 2012-02-01 Interventions: Drug: LFG316 LFG316 administer |
Completed |
Study Name: Quality of Life in Patients With Intermediate Uveitis Condition: Macular Edema Date: 2011-03-11 |
Recruiting |
Study Name: Intravitreal Sirolimus as Therapeutic Approach to Uveitis Condition: Uveitis Intermediate Uveitis Date: 2011-01-20 Interventions: Drug: Intravitreal injection 440mcg |
Completed |
Study Name: Assessment of Retinal Nerve Fibre Layer by Optical Coherence Tomography in Uveitis Patients With Papilloedema Condition: Uveitis Glaucoma Date: 2010-07-21 |
Completed |
Study Name: Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis Condition: Uveitis Date: 2010-05-14 Interventions: Drug: Adalimumab Administered |
Completed |
Study Name: Efficacy and Safety of Adalimumab in Patients With Active Uveitis Condition: Uveitis Date: 2010-05-14 Interventions: Biological: Adalimumab Adminis |
Completed |
Study Name: Myfortic for the Treatment of Non-infectious Intermediate Uveitis Condition: Uveitis, Intermediate Date: 2010-03-23 Interventions: Drug: Myfortic Myfortic 360 mg |
Recruiting |
Study Name: Sirolimus as Therapeutic Approach to Uveitis Condition: Uveitis Intermediate Uveitis Date: 2009-04-30 Interventions: Drug: Sirolimus (rapamycin) Wi |